>Sender: >To: >X-Original-Message-ID: <00a401bf40c5$9016c6d0$9acf69cf@pacbell.net> >From: "Peter McWilliams" >Subject: sigh >Date: Tue, 7 Dec 1999 07:13:05 -0800 >X-Mozilla-Status: 8001 >X-Mozilla-Status2: 00000000 > > >On December 6, 1999, Dr. Ethan Russo, U. Montana, heard >that NIDA's special review committee rejected his MAPS-supported, IRB-and >FDA-approved protocol, and that he will not be permitted to purchase >marijuana from NIDA for his study. Dr. Russo was told nothing about why the >protocol was rejected and was also told he should expect to wait a month or >longer before receiving any formal notification from NIDA. FDA gave its final >approval to the study months ago. > >A press release is being planned by the Marijuana Policy Project, which has >been lobbying against the new HHS guidelines for medical marijuana research >which permit NIDA to create its own special review committee to review >protocols that have already been approved by FDA and Institutional Review >Boards. All that Dr. Russo and MAPS have been seeking is the ability to >purchase low quality marijuana from NIDA at a price that has not yet been >made public. The sad truth is that NIDA is still successfully blocking >medical marijuana research. > >We are currently reassessing how to proceed with efforts to conduct >privately funded medical marijuana research. NIDA's monopoly control over >the supply of marijuana that can be used in FDA-approved research projects >highlights the importance of MAPS' long-term effort to obtain permission >from DEA to establish an independent facility to produce marijuana for >FDA-approved research. > > > >================================================================ > >This message is sent to you because you are subscribed to > the mailing list . >To unsubscribe, E-mail to: